Menu

About RedHill

RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary drugs for the treatment of gastrointestinal diseases.

The Company’s current product pipeline includes:

TALICIA® - An oral combination therapy for Helicobacter pylori infection, with an ongoing confirmatory Phase III study and positive results from a first Phase III study.

RHB-104 - An oral combination therapy with positive top-line results from a first Phase III study for Crohn's disease.

RHB-204 - An oral combination therapy with a planned pivotal Phase III study for nontuberculous mycobacteria (NTM) infections.

BEKINDA® (RHB-102) - A once-daily oral pill formulation of ondansetron with positive results from a Phase III study in acute gastroenteritis and gastritis and positive results from a Phase II study in IBS-D.

YELIVA® (ABC294640) - an orally-administered, first-in-class SK2 selective inhibitor, targeting multiple oncology, inflammatory and gastrointestinal indications, with an ongoing Phase IIa study for cholangiocarcinoma.

RHB-106 - An encapsulated formulation for bowel preparation licensed to Salix Pharmaceuticals Ltd.

RHB-107 (MESUPRON) - A Phase II-stage, orally-administered, first-in-class, serine protease inhibitor, targeting targeting gastrointestinal and other solid tumor cancers. 


RedHill commercializes and promotes four gastrointestinal products in the U.S.:

Donnatal® - a prescription oral adjunctive drug used in the treatment of IBS and acute enterocolitis.

Mytesi® - a prescription oral anti-diarrheal drug indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy (ART).

Esomeprazole Strontium Delayed-Release Capsules 49.3 mg - a prescription proton pump inhibitor indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal conditions.

EnteraGam® - a medical food intended for the dietary management, under medical supervision, of chronic diarrhea and loose stools.